Procurement of the drugs pembrolizumab, ublituximab, avapritinib and zanubrutinib until the conclusion of the Agreement after the implementation of the joint procurement procedure

This tender document contains detailed specifications, requirements, and submission guidelines. Purchase access to view the full document including eligibility criteria, scope of work, and evaluation methodology.

The complete document includes all annexes, terms of reference, and bidding instructions required for your submission.

Contact the procuring entity directly for pre-bid inquiries and clarifications.